SteelPeak Wealth LLC Takes $980,000 Position in Healthpeak Properties, Inc. $DOC

Key Points

• SteelPeak Wealth LLC acquired a new stake in Healthpeak Properties, purchasing 55,944 shares valued at approximately $980,000 in the second quarter.
• Other significant institutional investors, including UBS Asset Management and Goldman Sachs, have notably increased their holdings in Healthpeak Properties, showcasing strong interest in the company.
• Healthpeak Properties announced a monthly dividend of $0.1017 per share, resulting in an annualized yield of 6.5%, despite a high dividend payout ratio of 508.33%.

SteelPeak Wealth LLC bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 55,944 shares of the real estate investment trust's stock, valued at approximately $980,000.

Other large investors have also modified their holdings of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Healthpeak Properties by 584.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust's stock worth $186,405,000 after buying an additional 7,872,150 shares during the last quarter. Nuveen LLC bought a new position in Healthpeak Properties during the 1st quarter worth approximately $124,113,000. Invesco Ltd. lifted its holdings in Healthpeak Properties by 20.7% during the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock worth $467,311,000 after buying an additional 3,967,830 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in Healthpeak Properties by 57.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust's stock worth $136,785,000 after buying an additional 2,477,307 shares during the last quarter. Finally, Amundi lifted its holdings in Healthpeak Properties by 89.4% during the 1st quarter. Amundi now owns 5,047,699 shares of the real estate investment trust's stock worth $98,228,000 after buying an additional 2,382,657 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.

Insiders Place Their Bets

In other Healthpeak Properties news, CEO Scott M. Brinker acquired 2,930 shares of the company's stock in a transaction dated Thursday, July 31st. The shares were acquired at an average cost of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the purchase, the chief executive officer owned 210,416 shares of the company's stock, valued at approximately $3,589,696.96. This trade represents a 1.41% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders bought 8,783 shares of company stock worth $150,129 in the last 90 days. 0.23% of the stock is owned by company insiders.

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $18.86 on Thursday. Healthpeak Properties, Inc. has a 1-year low of $16.63 and a 1-year high of $23.26. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06. The company has a market capitalization of $13.11 billion, a price-to-earnings ratio of 78.59, a P/E/G ratio of 3.26 and a beta of 1.09. The stock's fifty day simple moving average is $17.97 and its 200-day simple moving average is $18.01.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. The business had revenue of $694.35 million for the quarter, compared to the consensus estimate of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.Healthpeak Properties's revenue for the quarter was down .2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 6.5%. The ex-dividend date is Friday, December 19th. Healthpeak Properties's dividend payout ratio (DPR) is 508.33%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on DOC. Wall Street Zen downgraded Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Weiss Ratings reissued a "hold (c-)" rating on shares of Healthpeak Properties in a report on Wednesday. Wells Fargo & Company cut their price target on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating on the stock in a report on Wednesday, August 27th. Raymond James Financial raised Healthpeak Properties from a "market perform" rating to an "outperform" rating and set a $20.00 price target on the stock in a report on Monday, September 15th. Finally, Cantor Fitzgerald began coverage on Healthpeak Properties in a report on Wednesday, October 1st. They issued a "neutral" rating and a $20.00 price target on the stock. Eight analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $21.33.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.